v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 459,174 $ 34,085
Prepaid expenses and other current assets 159,985 11,454
Total Current Assets 619,159 45,539
Non-Current Assets:    
Deferred equity issuance costs 193,876
Total Assets 619,159 239,415
Current Liabilities:    
Accounts payable- trade 1,512,090 1,361,081
Accrued expenses 596,465 1,049,910
Convertible notes payable, net of debt issuance costs and discounts 1,248,708
Derivative liability arising from convertible notes payable 544,957
Accrued interest 134,875
Total Current Liabilities 2,108,555 4,339,531
Total Liabilities 2,108,555 4,339,531
Commitments and contingencies (Note 11)
Stockholders’ Deficit:    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2025 and 2024
Common stock, $0.0001 par value, 50,000,000 shares authorized, 8,655,829 and 3,249,999 shares issued and outstanding as of December 31, 2025 and 2024, respectively [1] 866 325
Additional paid-in capital 7,801,539 23,791
Accumulated deficit (9,291,801) (4,124,232)
Total Stockholders’ Deficit (1,489,396) (4,100,116)
Total Liabilities and Stockholders’ Deficit $ 619,159 $ 239,415
[1] The number of shares and per share value of the Company’s common stock have been retroactively recast to reflect the exchange ratio pursuant to the Merger (see Note 3).